Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
IDEAYA Biosciences revenue
IDEAYA Biosciences's revenue is $7.0 million.
What is IDEAYA Biosciences's revenue?
- IDEAYA Biosciences's revenue growth from 2020 to 2024 is -64.17%.
- IDEAYA Biosciences has 69 employees, and the revenue per employee ratio is $101,449.
- IDEAYA Biosciences's peak quarterly revenue was $29.7M in 2022(q3).
- IDEAYA Biosciences peak revenue was $50.9M in 2022.
- IDEAYA Biosciences annual revenue for 2023 was 23.4M, -54.08% growth from 2022.
- IDEAYA Biosciences annual revenue for 2024 was 7.0M, -70.07% growth from 2023.
On this page
Zippia finds jobs where you're a top candidate and applies on your behalf.
IDEAYA Biosciences historical revenue
IDEAYA Biosciences's peak revenue was $50.9M in 2022. The peak quarterly revenue was $29.7M in 2022(q3).
IDEAYA Biosciences's revenue increased from $19.5m in 2020 to $7.0M currently. That's a -64.17% change in annual revenue.
IDEAYA Biosciences annual revenue
IDEAYA Biosciences annual revenue over time
| Fiscal year / year | IDEAYA Biosciences revenue |
|---|---|
| 2020 | $19.5M |
| 2021 | $27.9M |
| 2022 | $50.9M |
| 2023 | $23.4M |
| 2024 | $7.0M |
Rate IDEAYA Biosciences' financial transparency
IDEAYA Biosciences annual growth
IDEAYA Biosciences saw the greatest revenue growth in 2022, when revenue increased by 82.28%.
IDEAYA Biosciences had the lowest revenue growth in 2021, when revenue changed by 43.01%.
IDEAYA Biosciences annual growth rate over time
| Year | IDEAYA Biosciences growth |
|---|---|
| 2021 | 43%↑ |
| 2022 | 82%↑ |
| 2023 | -54%↓ |
| 2024 | -70%↓ |
IDEAYA Biosciences quarterly revenue over time
- Q1
- Q2
- Q3
- Q4
IDEAYA Biosciences quarterly growth rate over time
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2020 | - | - | $9.0M | $10.6M |
| 2021 | $7.2M | $8.8M | $9.0M | $3.0M |
| 2022 | $11.4M | $5.9M | $29.7M | $4.0M |
| 2023 | $7.9M | $3.5M | $8.0M | $3.9M |
IDEAYA Biosciences jobs nearby
Do you work at IDEAYA Biosciences?
Did IDEAYA Biosciences meet its revenue projections?
IDEAYA Biosciences financing
IDEAYA Biosciences received early financing of $46.0M on 2016-05-03.
| Series | Round size | Date |
|---|---|---|
| Series A | $46M | 05/2016 |
| Series B | $94M | 03/2018 |
| Post Ipo Equity | $86.1M | 07/2021 |
IDEAYA Biosciences investors
| Investors | Security type |
|---|---|
| Canaan Partners | Series A |
| CELGENE CORP /DE/ | Series A |
| 5 Am Ventures | Series A |
| Novartis Institutes | Series A |
| WuXi Healthcare Ventures | Series A |
| Alexandria Real Estate Equities, Inc. | Series A |
| 5 Am Ventures | Series B |
| Nextech Invest | Series B |
| Biotechnology Value Fund | Series B |
| WuXi Healthcare Ventures | Series B |
| Centene Corporation | Series B |
| Alexandria Venture Investments | Series B |
| DRIEHAUS CAPITAL MANAGEMENT | Series B |
| Canaan Partners | Series B |
| Perceptive Advisors | Series B |
| Roche Venture Fund | Series B |
| GV | Series B |
| Boxer Capital | Series B |
| 6 Dimensions Capital | Series B |
IDEAYA Biosciences competitors
IDEAYA Biosciences's top competitor, Rain Therapeutics, earned an annual revenue of $12.5B.
IDEAYA Biosciences's smallest competitor is Trillium Therapeutics with revenue of $148.0K last year.
| Company name | Average salary | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Cerecor | - | $6.7M | 32 | - |
| Turning Point Therapeutics | - | $25.0M | 142 | - |
| Tango Therapeutics | - | $42.1M | 91 | - |
| Rain Therapeutics | - | $12.5B | 17 | - |
| Trillium Therapeutics | - | $148,000 | 20 | - |
| Phoenix PharamLabs | - | $1.0M | 12 | - |
Search for jobs
Related company revenues
Working at related companies
Related company jobs
Most in demand jobs
Zippia gives an in-depth look into the details of IDEAYA Biosciences, including salaries, political affiliations, employee data, and more, in order to inform job seekers about IDEAYA Biosciences. The employee data is based on information from people who have self-reported their past or current employments at IDEAYA Biosciences. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by IDEAYA Biosciences. The data presented on this page does not represent the view of IDEAYA Biosciences and its employees or that of Zippia.
IDEAYA Biosciences may also be known as or be related to IDEAYA BIOSCIENCES, INC., IDEAYA Biosciences, IDEAYA Biosciences, Inc., Ideaya Biosciences and Ideaya Biosciences, Inc.